Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (SHE:300534)
China flag China · Delayed Price · Currency is CNY
10.24
+0.07 (0.69%)
At close: Feb 27, 2026

SHE:300534 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
3,1062,6392,9942,6914,4651,756
Market Cap Growth
25.34%-11.85%11.27%-39.74%154.23%-2.69%
Enterprise Value
3,1252,5062,9422,6084,4041,772
Last Close Price
10.248.679.788.7914.585.74
PE Ratio
111.55102.2748.5769.37-959.17
PS Ratio
3.402.542.773.3715.516.89
PB Ratio
4.103.634.213.056.092.38
P/TBV Ratio
5.184.515.373.576.812.67
P/FCF Ratio
-28.71-11.1288.0470.40
P/OCF Ratio
-15.5131.0210.0687.3240.38
EV/Sales Ratio
3.422.412.723.2615.306.95
EV/EBITDA Ratio
23.8818.4826.3431.31332.41101.07
EV/EBIT Ratio
35.6325.5435.9646.31--
EV/FCF Ratio
-16.9927.26-10.7886.8471.02
Debt / Equity Ratio
0.170.150.20--0.10
Debt / EBITDA Ratio
1.000.811.29--4.00
Debt / FCF Ratio
-1.19---2.81
Net Debt / Equity Ratio
-0.06-0.25-0.20-0.42-0.13-0.06
Net Debt / EBITDA Ratio
-0.36-1.33-1.29-4.43-7.48-2.74
Net Debt / FCF Ratio
0.26-1.964.84-1.53-1.95-1.93
Asset Turnover
0.680.760.810.750.340.30
Inventory Turnover
2.672.714.224.834.024.23
Quick Ratio
1.141.011.211.503.592.78
Current Ratio
1.601.301.481.794.523.22
Return on Equity (ROE)
6.31%7.21%10.52%6.02%-0.86%0.44%
Return on Assets (ROA)
4.07%4.48%3.85%3.29%-0.69%-0.15%
Return on Invested Capital (ROIC)
6.82%8.82%11.54%7.22%-1.41%-0.24%
Return on Capital Employed (ROCE)
9.10%11.10%9.10%6.20%-1.20%-0.30%
Earnings Yield
0.90%0.98%2.06%1.44%-0.20%0.10%
FCF Yield
-5.92%3.48%-1.00%9.00%1.14%1.42%
Dividend Yield
0.39%0.46%0.21%---
Payout Ratio
52.64%59.27%6.19%1.28%-272.45%
Buyback Yield / Dilution
0.10%0.05%-0.05%0.10%0.54%-0.56%
Total Shareholder Return
0.49%0.51%0.16%0.10%0.54%-0.56%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.